Metabolic intervention with GLP-1 to improve the function of ischemic and reperfused skeletal muscle tissue

Number of patents in Portfolio can not be more than 2000

United States of America Patent

APP PUB NO 20020147131A1
SERIAL NO

09953021

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Individuals in need of treatment of ischemia-related reperfusion are treated, preferably intravenously, with a composition which includes a compound which binds to a receptor for the glucagon-like peptide-1. The invention relates to both the method and compositions for such treatment.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
AMYLIN PHARMACEUTICALS INC9360 TOWNE CENTRE DRIVE SAN DEIGO CALIFORNIA UNITED STATES OF AMERICA

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Coolidge, Thomas R Falls Village, CT 27 1001
Ehlers, Mario RW Lincoln, NE 3 32

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation